Elevating bioavailability of cyclosporine A via encapsulation in artificial oil bodies stabilized by caleosin

Biotechnology Progress

Volumn 21, Issue 4, 2005, Pages 1297-1301

  Chen, Miles C M ^a   Wang, Jui Ling ^b   Tzen, Jason T C ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CONCENTRATION (PROCESS); DRUG THERAPY; ESCHERICHIA COLI; HYDROPHOBICITY; OILS AND FATS; PHOSPHOLIPIDS;

ARTIFICIAL OIL BODIES (AOB); BIOAVAILABILITY; BLOOD CONCENTRATION; CYCLOSPORINE;

DRUG PRODUCTS;

CALCIUM BINDING PROTEIN; CALEOSIN PROTEIN, SESAMUM INDICUM; CYCLOSPORIN; OLIVE OIL; RECOMBINANT PROTEIN; VEGETABLE OIL; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; DRUG FORMULATION; DRUG STABILITY; GENETICS; MALE; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM-BINDING PROTEINS; CYCLOSPORINE; DRUG COMPOUNDING; DRUG STABILITY; MALE; PLANT OILS; PLANT PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

ANIMALIA; ESCHERICHIA COLI; RATTUS NORVEGICUS;

EID: 23244462957     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp050030b     Document Type: Article

References (32)

1. Borel, J. F.; Gunn, H. C. Cyclosporin as a new approach to therapy of autoimmune diseases. Ann. N.Y. Acad. Sci. 1986, 457, 307-319.
2. Sajjadi, H.; Soheilian, M.; Ahmadieh, H.; Hussanein, K.; Parvin, M.; Azarmina, M.; Ehyaee, V.; Amiransari, B. Low dose cyclosporine-A therapy in Behcet's disease. J. Ocul. Pharmacol. 1994, 10, 553-560.
3. Richardson, C.; Emery, P. Clinical use of cyclosporine in rheumatoid arthiritis. Drugs 1995, 50, 26-36.
4. Koehler, J.; Kuehnel, T.; Kees, F.; Hoecherl, K.; Grobecker, H. F. Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine A in rats. Drug Metab. Dispos. 2002, 30, 658-662.
5. Ford, J.; Woolfe, J.; Florence, A. T. Nanospheres of cyclosporin A: poor oral absorption in dogs. Int. J. Pharm. 1999, 183, 3-6.
6. Zhang, Q.; Yie, G., Li, Y.; Yang, Q.; Nagai, T. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int. J. Pharm. 2000, 200, 153-159.
7. De Campos, A. M.; Sanchez, A.; Alonso, M. J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001, 224, 159-168.
8. El-Shabouri, M. H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm. 2002, 249, 101-108.
9. Ugazio, E.; Cavalli, R.; Gasco, M. R. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int. J. Pharm. 2002, 241, 341-344.
10. Bekerman, T.; Golenser, J.; Domb, A. Cyclosporin nanoparticulate lipospheres for oral administration. J. Pharm. Sci. 2004, 93, 1264-1270.
11. Tzen, J. T. C.; Wang, M. M. C.; Chen, J. C. F.; Lin, L. J.; Chen, M. C. M. Seed oil body proteins: oleosin, caleosin, and steroleosin. Curr. Top. Biochem. Res. 2003, 5, 133-139.
12. Chen, J. C. F.; Tsai, C. C. Y.; Tzen, J. T. C. Cloning and secondary structure analysis of caleosin, a unique calcium-binding protein in oil bodies of plant seeds. Plant Cell Physiol. 1999, 40, 1079-1086.
13. 2+ binding proteins associated with lipid bodies. Plant Mol. Biol. 2000, 44, 463-476.
14. Lin, L. J.; Sorgan, S. S. K.; Peng, C. C.; Tzen, J. T. C. Steroleosin, a sterol-binding dehydrogenase in seed oil bodies. Plant Physiol. 2002, 128, 1200-1211.
15. Lin, L. J.; Tzen, J. T. C. Two distinct steroleosins are present in seed oil bodies. Plant Physiol. Biochem. 2004, 42, 601-608.
16. Tzen, J. T. C.; Chuang, R. L. C.; Chen, J. C. F.; Wu, L. S. H. Coexistence of both oleosin isoforms on the surface of seed oil bodies and their individual stabilization to the organells. J. Biochem. 1998, 123, 319-324.
17. Tai, S. S. K.; Chen, M. C. M.; Peng, C. C.; Tzen, J. T. C. Gene family of oleosin isoforms in sesame seed oil bodies and their structural stabilization to reconstituted oil bodies. Biosci. Blotechnol. Biochem. 2002, 66, 2146-2153.
18. Peng, C. C.; Lin, I. P.; Lin, C. K.; Tzen, J. T. C. Size and stability of reconstituted sesame oil bodies. Biotechnol. Prog. 2003, 19, 1623-1626.
19. Chen, M. C. M.; Chyan, C. L.; Lee, T. T. T.; Hung, S. H.; Tzen, J. T. C. Constitution of stable artificial oil bodies with triacylglycerol, phospholipid, and caleosin. J. Agric. Food Chem. 2004, 52, 3982-3987.
20. Tzen, J. T. C.; Peng, C. C.; Cheng, D. J.; Chen, E. C. F.; Chiu, J. M. H. A new method for seed oil body purification and examination of oil body integrity following germination. J. Biochem. 1997, 121, 762-768.
21. Gibaldi, M.; Perrier, D. Pharmacokinetics; Marcel Dekker: New York, 1892.
22. Gershanik, T.; Benita, S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 2000, 50, 179-188.
23. Sass, W.; Dreyer, H. P.; Seifert, J. Rapid insorption of small particles in the gut. Am. J. Gastroenterol. 1990, 85, 255-260.
24. Swenson, E. S.; Milisen, W. B.; Curatolo, W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 1994, 11, 1132-1142.
25. Frandsen, G. I.; Mundy, J.; Tzen, J. T. C. Oil bodies and their associated proteins, oleosin and caleosin. Physiol. Plant 2001, 112, 301-307.
26. Christians, U.; Sewing, K. F. Cyclosporin metabolism in transplant patients. Pharmacol. Ther. 1993, 57, 291-345.
27. Watkins, P. B. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994, 4, 171-184.
28. Benet, L. Z.; Wu, C.-Y.; Hebert, M. F.; Wacher, V. J. Intestinal drug metabolism and antitransport processes: a potential paradigm shift in oral drug delivery. J. Controlled Release 1996, 39, 139-143.
29. Hou, R. C. W.; Lin, M. Y.; Wang, M. M. C.; Tzen, J. T. C. Increase of viability of entrapped cells of Lactobacillus delbrueckii ssp. Bulgaricus in artificial oil emulsion. J. Diary Sci. 2003, 86, 424-428.
30. Peng, C. C.; Chen, J. C. F.; Shyu, D. J. H.; Chen, M. J.; Tzen, J. T. C. A system for purification of recombinant proteins in Escherichia coli via artificial oil bodies constituted with their oleosin-fused polypeptides. J. Biotechnol. 2004, 111, 51-57.
31. Peng, C. C.; Shyu, D. J. H.; Chou, W. M.; Chen, M. J.; Tzen, J. T. C. Method for bacterial expression and purification of sesame cystatin via artificial oil bodies. J. Agric. Food Chem. 2004, 52, 3115-3119.
32. Chen, J. C. F.; Tzen, J. T. C. An in vitro system to examine the effective phospholipids and structural domain for protein targeting to seed oil bodies. Plant Cell Physiol. 2001, 42, 1245-1252.